The neurogenic effects of rosmarinic acid in a mouse model of type 2 diabetes mellitus
Braz. J. Pharm. Sci. (Online); 56 (), 2020
There is emerging evidence for a dysregulation of insulin signaling in the brains of patients with Alzheimer's disease (AD) with overlapping molecular features to Type 2 Diabetes Mellitus (T2DM). In addition, T2DM is a known risk factor of AD. The goal of this study was to investigate the neurogenic and ...